Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics.
about
Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease ProgressionHSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York CityHIV-prevention science at a crossroads: advances in reducing sexual risk.Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.HIV-1, HSV-2 and syphilis among pregnant women in a rural area of Tanzania: prevalence and risk factors.Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infectionsComparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings.Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs.Community-based prevention leads to an increase in condom use and a reduction in sexually transmitted infections (STIs) among men who have sex with men (MSM) and female sex workers (FSW): the Frontiers Prevention Project (FPP) evaluation results.Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa.Effect of variable transmission rate on the dynamics of HIV in sub-Saharan Africa.No evidence of association between HIV-1 and malaria in populations with low HIV-1 prevalence.Worsening epidemic of HIV and syphilis among men who have sex with men in Jiangsu Province, ChinaHeterogeneity of the HIV epidemic in the general population of Karnataka state, south IndiaPrevalence and correlates of bacterial vaginosis in different sub-populations of women in sub-Saharan Africa: a cross-sectional study.Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.Sexually transmitted infections among patients with herpes simplex virus at King Abdulaziz University Hospital.Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men.Prevalence and assessment of clinical management of sexually transmitted infections among female sex workers in two cities of India.Syphilis and its correlates among heterosexual males attending sexually transmitted infection clinics - observation from a multicity cohort in Jiangsu Province, China.The epidemic of HIV, syphilis, chlamydia and gonorrhea and the correlates of sexual transmitted infections among men who have sex with men in Jiangsu, China, 2009.Time to refocus on HSV interventions for HIV prevention?Gender and age patterns in HSV-2 and HIV infection among non-injecting drug users in New York City.Simultaneous delivery of tenofovir and acyclovir via an intravaginal ringEqual HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapyPopulation-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa.Serum TRSUT Titer ≥1: 16 Is a Predictor for Neurosyphilis Among HIV-Infected Patients With Concurrent Syphilis and No Neurological Symptoms.Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa.Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda.An intravaginal ring for the simultaneous delivery of multiple drugs.Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load.Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1.Effect of HSV-2 on population-level trends in HIV incidence in Uganda between 1990 and 2007.Correlates of chlamydia and gonorrhea infection among female sex workers: the untold story of Jiangsu, China.Modelling the interactions between herpes simplex virus type 2 and HIV: implications for the HIV epidemic in southern India.Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.Rapid host immune response and viral dynamics in herpes simplex virus-2 infection.Langerhans cells and sexual transmission of HIV and HSV.
P2860
Q26751304-876E9413-F7D3-4BF9-8A7D-CA14A731EE27Q28539412-E7D2D74D-8ECC-4B5E-B8D2-B197BA672841Q30378142-FCFB2B89-98E0-406A-85D7-CB8C21C91D73Q33336603-137EC1CC-61A2-4901-9432-A5ADAE6EB9DDQ33339044-53FD1218-5D57-420F-8A00-88CF3A88498EQ33436735-93E4B04B-3806-483E-B521-1559AF8C92F7Q33553333-035780DE-6BB2-4B17-B1DE-3197AA7FCACBQ33554048-A17B494A-8435-4906-81F1-1BECC048AA10Q33595097-E0FB48E9-7D87-4610-9B12-959F8223E18BQ33662678-0E0C78ED-C362-418F-9650-271E40141DA0Q33846776-03A671D8-94CD-40DC-AE06-D316C691E82BQ33990906-37F69600-DDC2-4EED-9C68-9EC62D0F8B47Q33999657-78FB4AB4-AFCE-4954-8598-DCACA9C8A4B1Q34106207-BBBFED34-A2A4-4EC2-9453-CCA0CB342A1FQ34178928-589AE05D-A3BF-4566-A482-D5CE04438B24Q34302658-36886D66-841C-4103-BBD9-8A058FA71BAFQ34495644-8D14667B-876A-4D49-AD82-B97624680BA5Q34881025-D0E6456B-89CC-4E1E-9F4D-EF4FCD98F9E8Q34991890-FF88C183-AE3E-4E49-86B0-9614C24C55ABQ35070742-C5391784-1041-4FAB-B9B8-3B2C64EA5892Q35152179-3B9561C6-33C4-4E04-8C42-B82ECCF8CADCQ35182229-22C3FB41-5A53-4CA7-BEE9-DD12D4CDF796Q35532849-5C808CE9-F569-48C7-888D-AE5C73ACD4BCQ35683923-72096808-8EBF-4059-8DD3-918EF828F337Q35689332-FAC927C3-A904-4217-AAC2-85A98803C77AQ35903432-DB946B1E-AE4A-47FC-81AC-804E0E098C2DQ37014624-473AB50D-ED9A-4BD6-9C6F-73A72BD93FCCQ37016802-A8B0F8C9-333B-4107-A85E-8B1D7874DFB3Q37182088-BD92589D-EC86-4180-8B09-65CE893472B7Q37201714-CD27A780-6CBC-49F8-B0E1-CA72CBBCE0EAQ37216301-C6AF5FC5-E27B-4EB8-9A5B-09F11A04CE88Q37379716-E86BF87D-D68F-4A11-9C39-EF5412FFCE43Q37390663-7CF01DE0-28E7-4ADB-A345-128B9E20A33AQ37450218-E0BE7464-B887-4AA0-B1E8-C0ACCA968A04Q37455685-A26C14BC-78C7-4233-83AE-76C71668950CQ37484410-09CF56F0-0A74-4709-8F6C-10925E4060A5Q37575589-4251397A-9047-43A4-ACF0-E562EAA2ED57Q37692477-59DE489B-EBF0-42D7-8138-CE0B0AB08E52Q37694574-71B2CCEA-2FAB-41DF-B334-A4E7AA662CB8Q39065427-D61F0D6B-97D3-4FCC-9874-08B2153CD4C8
P2860
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 April 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proportion of new HIV infectio ...... Saharan African HIV epidemics.
@en
Proportion of new HIV infectio ...... Saharan African HIV epidemics.
@nl
type
label
Proportion of new HIV infectio ...... Saharan African HIV epidemics.
@en
Proportion of new HIV infectio ...... Saharan African HIV epidemics.
@nl
prefLabel
Proportion of new HIV infectio ...... Saharan African HIV epidemics.
@en
Proportion of new HIV infectio ...... Saharan African HIV epidemics.
@nl
P2093
P50
P921
P356
P1476
Proportion of new HIV infectio ...... -Saharan African HIV epidemics
@en
P2093
Dik Habbema
Judith R Glynn
Kate K Orroth
Roel Bakker
P304
P356
10.1136/STI.2006.023549
P478
83 Suppl 1
P577
2007-04-03T00:00:00Z